Fully automated assay of glycohemoglobin with the Abbott IMx analyzer: novel approaches for separation and detection

Abstract

We describe a novel assay for measuring glycohemoglobin directly from anticoagulated whole blood with the Abbott IMx analyzer. The glycohemoglobin is labeled with a soluble polyanionic affinity reagent and the anionic complex is then captured with a cationic solid-phase matrix. Glycohemoglobin is quantified by measuring the quenching by heme of the static fluorescence from an added fluorophore. The assay is standardized to report both percent total glycohemoglobin (%GHb) and percent hemoglobin A1c (%HbA1c). Glucose, bilirubin, triglycerides, labile fraction, and hemoglobin variants do not interfere in the assay. Within- and between-run CVs are approximately 4-5%, with total CVs of approximately 6.5%. Highly significant linear correlations (r > 0.97) were obtained in comparison studies with two major assay methodologies. The time to obtain one result is approximately 10 min (including assay of a control), 56 min for 22 results. We describe the development, standardization, and validation of this new method.

Effects of self‐management training in Type 2 diabetes: a randomized, prospective trial

“…The mean normal value for non-diabetic persons was 4.8 ± 0.4% (range 4.0 -5.6%). Since HbA 1c values with a normal range between 4.1 and 6.1% are commonly used to assess glycaemic control, the glycated heamoglobin values were linearly transformed to HbA 1c values with an upper normal range of 6.1% according to a linear regression formula provided by Wilson et al [27].…”

Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus

“…The glucose level in the maternal blood of STZ-treated and control animals was measured on day 19 of pregnancy with a commercially available glucometer (Accutrend; Boehringer Mannheim GmbH, Mannheim, Germany) according to the manufacturer's instructions. HbA 1 c level was measured by the Abbott IMx Glycated Hemoglobin assay (Abbott Laboratory, Abbott Park, Ill., USA) which is an ion capture assay using boronate affinity binding to measure the percentage of glycated haemoglobin (%Hb), and is also standardized to report the percentage of haemoglobin A 1 c [16].…”

Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes

“…In our previous study [8], 53 patients with Type 2 diabetes, all fulfilling ADA criteria [9], had been recruited consecutively from a hospital specializing in diabetes treatment. They had poor metabolic control (total glycosylated-haemoglobin value > 10.5%, equivalent to HbA 1c > 8.3%; [10]). Patients were assessed for cognitive functioning at admission and 2 weeks following the reestablishment of metabolic control.…”